microRNA-137 inhibits Tau hyperphosphorylation in Alzheimer’s disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells [26]. This evidence concerns the gene MAPT and neuroblastoma.